Cookie Consent by PrivacyPolicies.com

Publicaciones científicas

141 Publicaciones científicas disponibles

  • Posttransplant management of recipients undergoing liver transplantation for hepatocellular carcinoma

    23 de marzo de 2020 | Revista: Transplantation

    Berenguer M (1), Burra P (2), Ghobrial M (3), Hibi T (4), Metselar H (5), Sapisochin G (6), Bhoori S (7), Man NK (8), Mas V (9), Ohira M (10), Sangro B (11), van der Laan LJW (12).

    (1) Hepatology - Liver Transplantation Unit, Digestive Medicine Service, IIS La Fe and CIBER-EHD, Hospital Universitari i Politècnic La Fe, Valencia, Spain and Department of Medicine, Universitat de València, Valencia, Spain.
    (2) Multivisceral Transplant Unit, Gastroenterology. Department of Surgery, Oncology and Gastroenterology. Padua University Hospital. Padua Italy.
    (3) J C Walter Jr Transplant Center, Sherrie and Alan Conover Center for Liver Disease and Transplantation, Weill Cornell Medical College, Houston Methodist Hospital and Research Institute, Houston, TX, USA.
    (4) Kumamoto University Graduate School of Medical Sciences (Kumamoto, Japan).
    (5) Department of Gastroenterology and Hepatology, Erasmus MC - University Medical Center Rotterdam, the Netherlands.
    (6) Multi-Organ Transplant Program, Division of General Surgery, Toronto General Hospital, University Health Network, University of Toronto, Toronto, Canada.
    (7) Gastro-Hepato-Pancreatic Surgery and Liver Transplant Unit, Istituto Nazionale Tumori, Milan Italy.
    (8) Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.
    (9) Transplant Research Institute, James D. Eason Transplant Institute, Department of Surgery. The University of Tennessee Health Science Center.
    (10) Medical Center for Translational and Clinical Research, Hiroshima University Hospital, Hiroshima, JAPAN.
    (11) Clínica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
    (12) Department of Surgery, Erasmus MC - University Medical Center Rotterdam, The Netherlands.


  • Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma

    14 de agosto de 2019 | Revista: Journal of Hepatology

    Ricke J (1), Klumpen HJ (2), Amthauer H (3), Bargellini I (4), Bartenstein P (5), de Toni E (6), Gasbarrini A (7), Pech M (8), Peck-Radosavljevic M (9), Popovič P (10), Rosmorduc O (11), Schott E (12), Seidensticker M (13), Verslype C (14), Sangro B (15), Malfertheiner P (16).

    (1) Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
    (2) Department of Medical Oncology, Amsterdam University Medical Centers, University of Amsterdam, Meibergdreef 9, Amsterdam, The Netherlands.
    (3) Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, Berlin, Germany.
    (4) Department of Interventional Radiology, Pisa University Hospitalvia Paradisa 2, 56100 Pisa, Italy.
    (5) Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
    (6) Department of Medicine II, Liver Center Munich, University Hospital, Munich, Germany.
    (7) Internal Medicine, Gastroenterology and Hepatic Diseases Unit, IRCCS Fondazione Policlinico Universitario A. Gemelli, Università Cattolica del Sacro Cuore, Rome, Italy.
    (8) Department of Radiology and Nuclear Medicine, University of Magdeburg, Leipziger Str.44, 39120, Magdeburg, Germany.
    (9) Department of Internal Medicine and Gastroenterology, Klinikum Klagenfurt am Wörthersee, Klagenfurt, Austria.
    (10) Clinical Institute of Radiology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
    (11) APHP, Hôpital La Pitié Salpêtrière, Service d'Hépato-Gastroentérologie, Paris, France.
    (12) Department of Gastroenterology, Hepatology and Diabetology, Internal Medicine II, HELIOS Hospital Emil von Behring, Berlin, Germany.
    (13) University Hospital, LMU Munich, Munich, Germany.
    (14) Department of Digestive Oncology, University Hospital Leuven, Leuven, Belgium.
    (15) Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
    (16) Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.


  • Identification of coding and long non-coding RNAs differentially expressed in tumors and preferentially expressed in healthy tissues

    6 de agosto de 2019 | Revista: Cancer Research

    Unfried JP (1), Serrano G (2), Suárez B (1), Sangro P (3), Ferretti V (1), Prior C (4), Boix L (5), Bruix J (5), Sangro B (6), Segura V (7), Fortes P (8).

    (1) Division of Gene Therapy and Hepatology, Foundation for Applied Medical Research.
    (2) Bioinformatics Platform, Foundation for Applied Medical Research.
    (3) Liver Unit, Clínica Universidad de Navarra.
    (4) Division of Oncology, CIMA, University of Navarra.
    (5) BCLC group, Hospital Clinic-IDIBAPS and CIBEREHD.
    (6) Liver Unit, Clínica Universidad de Navarra-IDISNA and CIBEREHD.
    (7) Division of Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), and University Clinic, University of Navarra.
    (8) Division of Gene Therapy and Hepatology, CIMA, IDISNA


  • Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    29 de octubre de 2018 | Revista: Annals of Oncology

    Vogel A (1), Cervantes A (2), Chau I (3), Daniele B (4), Llovet JM (5), Meyer T (6), Nault JC (7), Neumann U (8), Ricke J (9), Sangro B (10), Schirmacher P (11), Verslype C (12), Zech CJ (13), Arnold D (14), Martinelli E (15); ESMO Guidelines Committee.

    (1) Department of Gastroenterology, Hepatology and Endocrinology, Medical School Hannover, Hannover, Germany.
    (2) Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia, Spain.
    (3) Department of Medicine, Royal Marsden Hospital, Surrey, UK.
    (4) Dipartimento di Oncologia, A. O. G. Rummo, Benevento, Italy.
    (5) Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, Mount Sinai Liver Cancer Program, New York, USA; Barcelona-Clínic Liver Cancer Group (BCLC), Unitat d'Hepatologia, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, Universitat de Barcelona, Barcelona; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
    (6) Oncology, Royal Free Hospital, London; UCL Cancer Institute, University College London, London, UK.
    (7) Service d'hépatologie, Hôpital Jean Verdier, Bondy, France.
    (8) Klinik für Allgemein- und Viszeralchirurgie, Medizinische Fakultät der RWTH Aachen.
    (9) Klinik und Poliklinik für Radiologie, Ludwig-Maximilians-Universität München, Munich, Germany.
    (10) Liver Unit, Clinica Universidad de Navarra-IDISNA and CIBEREHD, Pamplona, Spain.
    (11) Institute of Pathology, University Hospital, Heidelberg, Germany.
    (12) Campus Gasthuisberg, UZ Leuven, Leuven, Belgium.
    (13) Klinik für Radiologie und Nuklearmedizin Universität Basel, Basel, Switzerland.
    (14) Department Oncology, Section Hematology and Palliative Care AK Altona, Asklepios Tumorzentrum Hamburg, Hamburg, Germany.
    (15) Faculty of Medicine, Università della Campania L. Vanvitelli Naples, Caserta, Italy.

No hay más publicaciones científicas

No hay más páginas para cargar